Bruce Bernstein insider trades: Synaptogenix (SNPX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bruce reports to the SEC
and 5 more companies
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | SNPX | ↓ Sell10b5-1 | 22,500 | $1.17 | $26K | Direct | Dec 20, 2022 (4d) |
| Dec 1, 2022 | XWEL | ↑ Buy | 50,000 | $0.42 | $21K | Direct | Dec 1, 2022 (0d) |
| Mar 17, 2022 | XSPA | ↑ Buy | 5,000 | $1.23 | $6K | Direct | Mar 21, 2022 (4d) |
| Mar 7, 2022 | XSPA | ↓ Sell | 15,000 | $1.00 | $15K | Direct | Mar 9, 2022 (2d) |
| Jan 21, 2022 | XSPA | ↓ Sell | 25,000 | $1.46 | $37K | Direct | Jan 24, 2022 (3d) |
| Dec 17, 2021 | XSPA | ↑ Buy | 37,500 | $1.70 | $64K | Direct | Dec 17, 2021 (0d) |
| Aug 19, 2021 | XSPA | ↓ Sell | 107,500 | $1.43 | $153K | Direct | Aug 19, 2021 (0d) |
| May 23, 2018 | XSPA | ↑ Buy | 19,601 | $0.39 | $8K | Direct | May 23, 2018 (0d) |
| Aug 15, 2017 | FH | ↑ Buy | 6,500 | $1.14 | $7K | Direct | Aug 21, 2017 (6d) |
| Aug 14, 2017 | FH | ↑ Buy | 3,000 | $1.14 | $3K | Direct | Aug 15, 2017 (1d) |
| May 18, 2017 | FH | ↑ Buy | 23,700 | $1.61 | $38K | Direct | May 19, 2017 (1d) |
| Dec 2, 2016 | NTRP | ↑ Buy | 50,000 | $0.28 | $14K | Direct | Dec 2, 2016 (0d) |
| Nov 15, 2016 | FH | ↑ Buy | 1,960 | $2.35 | $5K | Direct | Nov 17, 2016 (2d) |
| Nov 11, 2016 | FH | ↑ Buy | 8,000 | $2.19 | $18K | Direct | Nov 15, 2016 (4d) |
| Sep 14, 2016 | FH | ↑ Buy | 11,430 | $2.10 | $24K | Direct | Sep 15, 2016 (1d) |
| Sep 12, 2016 | FH | ↑ Buy | 10,700 | $2.10 | $22K | Direct | Sep 14, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bruce Bernstein's insider trades
Bruce Bernstein is a director at Synaptogenix (SNPX). Since Sep 12, 2016, Bruce has reported 12 open-market purchases worth $230K and 4 sales worth $231K on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (11% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (61 filings), shares withheld for taxes (2 filings), option exercises (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNPX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.